FOXP3 expression accurately defines the population of intratumoral regulatory T cells that selectively accumulate in metastatic melanoma lesions

被引:111
作者
Ahmadzadeh, Mojgan [1 ]
Felipe-Silva, Aloisio [2 ]
Heemskerk, Bianca [1 ]
Powell, Daniel J., Jr. [1 ]
Wunderlich, John R. [1 ]
Merino, Maria J. [2 ]
Rosenberg, Steven A. [1 ]
机构
[1] NCI, Surg Branch, NIH, Bethesda, MD 20892 USA
[2] NCI, Pathol Lab, NIH, Bethesda, MD 20892 USA
关键词
D O I
10.1182/blood-2008-06-163048
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Regulatory T(T-reg) cells are often found in human tumors; however, their functional characteristics have been difficult to evaluate due to low cell numbers and the inability to adequately distinguish between activated and T-reg cell populations. Using a novel approach, we examined the intracellular cytokine production capacity of tumor-infiltrating T cells in the single-cell suspensions of enzymatically digested tumors to differentiate T-reg cells from effector T cells. Similar to T-reg cells in the peripheral blood of healthy individuals, tumor-infiltrating FOXP3 + CD4 T cells, unlike FOXP3 + T cells, were unable to produce IL-2 and IFN-gamma upon ex vivo stimulation, indicating that FOXP3 expression is a valid biological marker for human T-reg cells even in the tumor microenvironment. Accordingly, we enumerated FOXP3 + CD4 T-reg cells in intratumoral and peritumoral sections of metastatic melanoma tumors and found a significant increase in proportion of FOXP3 + CD4 T-reg cells in the intratumoral compared with peritumoral areas. Moreover, their frequencies were 3-to 5-fold higher in tumors than in peripheral blood from the same patients or healthy donors, respectively. These findings demonstrate that the tumor-infiltrating CD4 T-reg cell population is accurately depicted by FOXP3 expression, they selectively accumulate in tumors, and their frequency in peripheral blood does not properly reflect tumor microenvironment. (Blood. 2008; 112: 4953-4960)
引用
收藏
页码:4953 / 4960
页数:8
相关论文
共 45 条
  • [1] IL-2 administration increases CD4+CD25hi Foxp3+ regulatory T cells in cancer patients
    Ahmadzadeh, M
    Rosenberg, ST
    [J]. BLOOD, 2006, 107 (06) : 2409 - 2414
  • [2] IL-2 and IL-15 each mediate de novo induction of FOXP3 expression in human tumor antigen-specific CD8 T cells
    Ahmadzadeh, Mojgan
    Antony, Paul A.
    Rosenberg, Steven A.
    [J]. JOURNAL OF IMMUNOTHERAPY, 2007, 30 (03) : 294 - 302
  • [3] CD8+T cell immunity against a tumor/self-antigen is augmented by CD4+ T helper cells and hindered by naturally occurring T regulatory cells
    Antony, PA
    Piccirillo, CA
    Akpinarli, A
    Finkelstein, SE
    Speiss, PJ
    Surman, DR
    Palmer, DC
    Chan, CC
    Klebanoff, CA
    Overwijk, WW
    Rosenberg, SA
    Restifo, NP
    [J]. JOURNAL OF IMMUNOLOGY, 2005, 174 (05) : 2591 - 2601
  • [4] Interleukin 2-dependent mechanisms of tolerance and immunity in vivo
    Antony, Paul A.
    Paulos, Chrystal M.
    Ahmadzadeh, Mojgan
    Akpinarli, Akgul
    Palmer, Douglas C.
    Sato, Noriko
    Kaiser, Andrew
    Heinrichs, Christian
    Klebanoff, Christopher A.
    Tagaya, Yutaka
    Restifo, Nicholas P.
    [J]. JOURNAL OF IMMUNOLOGY, 2006, 176 (09) : 5255 - 5266
  • [5] Inability of a fusion protein of IL-2 and diphtheria toxin (Denileukin Diftitox, DAB389IL-2, ONTAK) to eliminate regulatory T lymphocytes in patients with melanoma
    Attia, P
    Maker, AV
    Haworth, LR
    Rogers-Freezer, L
    Rosenberg, SA
    [J]. JOURNAL OF IMMUNOTHERAPY, 2005, 28 (06) : 582 - 592
  • [6] Human CD4+CD25+ regulatory T cells
    Baecher-Allan, C
    Viglietta, V
    Hafler, DA
    [J]. SEMINARS IN IMMUNOLOGY, 2004, 16 (02) : 89 - 97
  • [7] CD4+CD25high regulatory cells in human peripheral blood
    Baecher-Allan, C
    Brown, JA
    Freeman, GJ
    Hafler, DA
    [J]. JOURNAL OF IMMUNOLOGY, 2001, 167 (03) : 1245 - 1253
  • [8] TCR stimulation with modified anti-CD3 mAb expands CD8+ T cell population and induces CD8+CD25+ Tregs
    Bisikirska, B
    Colgan, J
    Luban, J
    Bluestone, JA
    Herold, KC
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 2005, 115 (10) : 2904 - 2913
  • [9] Conversion of peripheral CD4+CD25- naive T cells to CD4+CD25+ regulatory T cells by TGF-β induction of transcription factor Foxp3
    Chen, WJ
    Jin, WW
    Hardegen, N
    Lei, KJ
    Li, L
    Marinos, N
    McGrady, G
    Wahl, SM
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 2003, 198 (12) : 1875 - 1886
  • [10] Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival
    Curiel, TJ
    Coukos, G
    Zou, LH
    Alvarez, X
    Cheng, P
    Mottram, P
    Evdemon-Hogan, M
    Conejo-Garcia, JR
    Zhang, L
    Burow, M
    Zhu, Y
    Wei, S
    Kryczek, I
    Daniel, B
    Gordon, A
    Myers, L
    Lackner, A
    Disis, ML
    Knutson, KL
    Chen, LP
    Zou, WP
    [J]. NATURE MEDICINE, 2004, 10 (09) : 942 - 949